A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00386958|
Recruitment Status : Completed
First Posted : October 12, 2006
Last Update Posted : August 23, 2016
|Condition or disease||Intervention/treatment||Phase|
|Infected Corneal Ulcers Bacterial Keratitis Corneal Ulcer Childhood Blindness||Drug: Povidone-Iodine||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||172 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers|
|Study Start Date :||November 2002|
|Actual Primary Completion Date :||January 2006|
|Actual Study Completion Date :||January 2006|
- Days to cure, with corneal epithelial defect closed, and no inflammatory signs other than minimal injection.
- Safety of study medication use compared to control medications. No untoward reactions or loss of visual acuity (VA) compared with pre-treatment VA findings.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00386958
|United States, California|
|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|
|Torrance, California, United States, 90502|
|Principal Investigator:||Sherwin J. Isenberg, M.D.||Jules Stein Eye Institute and Harbor-UCLA Medical Center|